202 related articles for article (PubMed ID: 22446839)
1. Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism.
Pollak Y; Mechlovich D; Amit T; Bar-Am O; Manov I; Mandel SA; Weinreb O; Meyron-Holtz EG; Iancu TC; Youdim MB
J Neural Transm (Vienna); 2013 Jan; 120(1):37-48. PubMed ID: 22446839
[TBL] [Abstract][Full Text] [Related]
2. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
[TBL] [Abstract][Full Text] [Related]
3. The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage.
Mechlovich D; Amit T; Mandel SA; Bar-Am O; Bloch K; Vardi P; Youdim MB
J Pharmacol Exp Ther; 2010 Jun; 333(3):874-82. PubMed ID: 20237072
[TBL] [Abstract][Full Text] [Related]
4. The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice.
Mechlovich D; Amit T; Bar-Am O; Mandel S; Youdim MB; Weinreb O
Curr Alzheimer Res; 2014 Feb; 11(2):119-27. PubMed ID: 24359498
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice.
Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Weinreb O
Mech Ageing Dev; 2012 May; 133(5):267-74. PubMed ID: 22426424
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
7. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
Gal S; Zheng H; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
[TBL] [Abstract][Full Text] [Related]
8. Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice.
Kupershmidt L; Amit T; Bar-Am O; Weinreb O; Youdim MB
Mol Neurobiol; 2012 Aug; 46(1):217-20. PubMed ID: 22847630
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus.
Mechlovich D; Amit T; Bar-Am O; Weinreb O; Youdim MB
Br J Pharmacol; 2014 Dec; 171(24):5636-49. PubMed ID: 25073425
[TBL] [Abstract][Full Text] [Related]
10. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
Salkovic-Petrisic M; Knezovic A; Osmanovic-Barilar J; Smailovic U; Trkulja V; Riederer P; Amit T; Mandel S; Youdim MB
Life Sci; 2015 Sep; 136():108-19. PubMed ID: 26159898
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
Bar-Am O; Amit T; Kupershmidt L; Aluf Y; Mechlovich D; Kabha H; Danovitch L; Zurawski VR; Youdim MB; Weinreb O
Neurobiol Aging; 2015 Mar; 36(3):1529-42. PubMed ID: 25499799
[TBL] [Abstract][Full Text] [Related]
12. Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.
Sofic E; Salkovic-Petrisic M; Tahirovic I; Sapcanin A; Mandel S; Youdim M; Riederer P
J Neural Transm (Vienna); 2015 Apr; 122(4):559-64. PubMed ID: 25252744
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30.
Avramovich-Tirosh Y; Bar-Am O; Amit T; Youdim MB; Weinreb O
Curr Alzheimer Res; 2010 Jun; 7(4):300-6. PubMed ID: 20043814
[TBL] [Abstract][Full Text] [Related]
14. Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.
Kupershmidt L; Weinreb O; Amit T; Mandel S; Bar-Am O; Youdim MB
Neuroscience; 2011 Aug; 189():345-58. PubMed ID: 21570450
[TBL] [Abstract][Full Text] [Related]
15. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
Golko-Perez S; Mandel S; Amit T; Kupershmidt L; Youdim MB; Weinreb O
Neurotox Res; 2016 Feb; 29(2):208-17. PubMed ID: 26581376
[TBL] [Abstract][Full Text] [Related]
16. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease.
Avramovich-Tirosh Y; Amit T; Bar-Am O; Zheng H; Fridkin M; Youdim MB
J Neurochem; 2007 Jan; 100(2):490-502. PubMed ID: 17144902
[TBL] [Abstract][Full Text] [Related]
18. The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30.
Youdim MB
Curr Alzheimer Res; 2006 Dec; 3(5):541-50. PubMed ID: 17168653
[TBL] [Abstract][Full Text] [Related]
19. M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease.
Gal S; Fridkin M; Amit T; Zheng H; Youdim MB
J Neural Transm Suppl; 2006; (70):447-56. PubMed ID: 17017567
[TBL] [Abstract][Full Text] [Related]
20. Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.
Weinreb O; Mandel S; Bar-Am O; Amit T
J Neural Transm (Vienna); 2011 Mar; 118(3):479-92. PubMed ID: 21360301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]